Liraglutide (LG), a glucagon-like peptide-1 (GLP-1) receptor agonist, is approved for treating type 2 diabetes mellitus and as a weight loss drug in obesity. Recently, LG has emerged as a promising neuroprotective agent in suppressing neuroinflammation by modulating disease-associated inflammatory pathways in various...
Abstract An orthotopically xenografted mouse GL26 glioma model (Ccr2RFP/wt-Cx3cr1GFP/wt) was used to evaluate the effect of transient, focal opening of the Blood Brain Barrier (BBB) on the composition of tumor-associated macrophages and microglia (TAMs). Opening of the BBB was induced by Magnetic Resonance Imaging (MRI...
Yan-Rong Zhang, Jing Wang, Sara Natasha Ghobadi et al.· Research Square· 0 citations
Triple-negative breast cancer (TNBC) remains one of the most difficult malignancies to treat owing to high relapse, enrichment of cancer stem cells (CSCs), and constitutive activation of pro-survival signaling such as NF-κB. We conceived a new therapeutic concept-A Priori Activation of Apoptosis Pathways (AAAPT)-design...
Raghu S Pandurangi, M. Tomasetti, Sekar T Verapazham et al.· Journal of drug targeting (P...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.